Literature DB >> 30281416

Poor Splice-Site Recognition in a Humanized Zebrafish Knockin Model for the Recurrent Deep-Intronic c.7595-2144A>G Mutation in USH2A.

Ralph Slijkerman1,2, Alexander Goloborodko3, Sanne Broekman1,4, Erik de Vrieze1,4, Lisette Hetterschijt1,4, Theo Peters1,4, Milou Gerits3, Hannie Kremer1,3,4, Erwin van Wijk1,4.   

Abstract

The frequent deep-intronic c.7595-2144A>G mutation in intron 40 of USH2A generates a high-quality splice donor site, resulting in the incorporation of a pseudoexon (PE40) into the mature transcript that is predicted to prematurely terminate usherin translation. Aberrant USH2A pre-mRNA splicing could be corrected in patient-derived fibroblasts using antisense oligonucleotides. With the aim to study the effect of the c.7595-2144A>G mutation and USH2A splice redirection on retinal function, a humanized zebrafish knockin model was generated, in which 670 basepairs of ush2a intron 40 were exchanged for 557 basepairs of the corresponding human sequence using an optimized CRISPR/Cas9-based protocol. However, in the retina of adult homozygous humanized zebrafish, only 7.4% ± 3.9% of ush2a transcripts contained the human PE40 sequence and immunohistochemical analyses revealed no differences in the usherin expression and localization between the retina of humanized and wild-type zebrafish larvae. Nevertheless, we were able to partially correct aberrant ush2a splicing using a PE40-targeting antisense morpholino. Our results indicate a clear difference in splice-site recognition by the human and zebrafish splicing machinery. Therefore, we propose a protocol in which the effect of human splice-modulating mutations is studied in a zebrafish-specific cell-based splice assay before the generation of a humanized zebrafish knockin model.

Entities:  

Keywords:  CRISPR/Cas9; minigene splice assay; retinal degeneration; splicing; usher syndrome

Mesh:

Substances:

Year:  2018        PMID: 30281416     DOI: 10.1089/zeb.2018.1613

Source DB:  PubMed          Journal:  Zebrafish        ISSN: 1545-8547            Impact factor:   1.985


  12 in total

Review 1.  Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction.

Authors:  Michelle L Hastings; Timothy A Jones
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies.

Authors:  Renske Schellens; Erik de Vrieze; Ralph Slijkerman; Hannie Kremer; Erwin van Wijk
Journal:  Methods Mol Biol       Date:  2022

3.  Clinical and preclinical therapeutic outcome metrics for USH2A-related disease.

Authors:  Maria Toms; Adam M Dubis; Erik de Vrieze; Dhani Tracey-White; Andreas Mitsios; Matthew Hayes; Sanne Broekman; Sarah Baxendale; Nattawan Utoomprurkporn; Doris Bamiou; Maria Bitner-Glindzicz; Andrew R Webster; Erwin Van Wijk; Mariya Moosajee
Journal:  Hum Mol Genet       Date:  2020-07-21       Impact factor: 6.150

4.  Modeling Retinitis Pigmentosa: Retinal Organoids Generated From the iPSCs of a Patient With the USH2A Mutation Show Early Developmental Abnormalities.

Authors:  Yonglong Guo; Peiyuan Wang; Jacey Hongjie Ma; Zekai Cui; Quan Yu; Shiwei Liu; Yunxia Xue; Deliang Zhu; Jixing Cao; Zhijie Li; Shibo Tang; Jiansu Chen
Journal:  Front Cell Neurosci       Date:  2019-08-07       Impact factor: 5.505

5.  From gene to treatment: supporting rare disease translational research through model systems.

Authors:  Julija Hmeljak; Monica J Justice
Journal:  Dis Model Mech       Date:  2019-02-22       Impact factor: 5.758

Review 6.  Application of CRISPR Tools for Variant Interpretation and Disease Modeling in Inherited Retinal Dystrophies.

Authors:  Carla Fuster-García; Belén García-Bohórquez; Ana Rodríguez-Muñoz; José M Millán; Gema García-García
Journal:  Genes (Basel)       Date:  2020-04-27       Impact factor: 4.096

7.  Genetic compensation prevents myopathy and heart failure in an in vivo model of Bag3 deficiency.

Authors:  Federica Diofano; Karolina Weinmann; Isabelle Schneider; Kevin D Thiessen; Wolfgang Rottbauer; Steffen Just
Journal:  PLoS Genet       Date:  2020-11-02       Impact factor: 5.917

8.  Small fish, big prospects: using zebrafish to unravel the mechanisms of hereditary hearing loss.

Authors:  Barbara Vona; Julia Doll; Michaela A H Hofrichter; Thomas Haaf; Gaurav K Varshney
Journal:  Hear Res       Date:  2020-02-06       Impact factor: 3.208

Review 9.  Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2.

Authors:  M Stemerdink; B García-Bohórquez; R Schellens; G Garcia-Garcia; E Van Wijk; J M Millan
Journal:  Hum Genet       Date:  2021-07-30       Impact factor: 4.132

10.  Modeling ZNF408-Associated FEVR in Zebrafish Results in Abnormal Retinal Vasculature.

Authors:  Dyah W Karjosukarso; Zaheer Ali; Theo A Peters; Jia Qi Cheng Zhang; Anita D M Hoogendoorn; Alejandro Garanto; Erwin van Wijk; Lasse D Jensen; Rob W J Collin
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.